Clinical Trials

An open label, randomised, active-controlled, parallel group, multicentre, phase 3 study to investigate the safety and efficacy of PA21 (Velphoro) and calcium acetate (Phoslyra) in pediatric and adolescent CKD patients with hyperphosphataemia.


Research Study Number:
PRO2016-0189

Short Title:
Velphoro and Phoslyra in CKD

Division:
Nephrology

Study Status:
Enrolling